Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Infectious Disease Modelling|March 6, 2024
Redefining pandemic preparedness: Multidisciplinary insights from the CERP modelling workshop in infectious diseases, workshop reportMarta C Nunes, Edward Thommes, Holger Fröhlich, et al.
Nature Communications|April 10, 2024
The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virusAnnefleur C Langedijk, Bram Vrancken, Robert Jan Lebbink, et al.
The Lancet. Infectious Diseases|June 20, 2018
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidatesNatalie I Mazur, Deborah Higgins, Marta C Nunes, et al.
American Journal of Respiratory and Critical Care Medicine|January 16, 2024
SARS-CoV-2 Viral Replication Persists in the Human Lung for Several Weeks after Symptom OnsetMichele Tomasicchio, Shameem Jaumdally, Lindsay Wilson, et al.
The Lancet. Infectious Diseases|August 11, 2022
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscapeNatalie I Mazur, Jonne Terstappen, Ranju Baral, et al.
The Lancet. Infectious Diseases|March 20, 2023
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing dataDeidre Wilkins, Annefleur C Langedijk, Robert Jan Lebbink, et al.
BMJ Open|January 8, 2026
Association of influenza viral genetic information with severity markers in patients hospitalised with influenza: multicentre retrospective cohort studyAung Pone Myint, George Shirreff, Vicky Baillie, et al.
Influenza and Other Respiratory Viruses|March 13, 2025
The Global Influenza Hospital Surveillance Network: A Multicountry Public Health CollaborationMarta C Nunes, Cecile Chauvel, Sonia M Raboni, et al.
Cell|July 9, 2021
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serumChang Liu, Helen M Ginn, Wanwisa Dejnirattisai, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesWanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
Pageof 15